Autres langues Vivos Therapeutics, Inc.

Actions

VVOS

US92859E2072

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 08/05/2024			Varia. 5j.	Varia. 1 janv.
2,375 ^USD	-2,26%		-6,27%	-80,91%

01/04	Les signes de ralentissement de l'inflation alimentent des gains étroits pour les contrats à terme d'actions américaines en préambule au marché.	MT
01/04	Les plus mauvais élèves du prémarché	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Vivos Therapeutics : Material Event - Form 8-K	06/05
Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices	09/04
Vivos Therapeutics : rsquo; Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement	09/04
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures	01/04
Top Premarket Decliners	01/04
Vivos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Earnings Flash (VVOS) VIVOS THERAPEUTICS Posts Q4 Revenue $3.2M	28/03
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update	28/03
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call	28/03
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds	15/02
Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions	12/02
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities	06/02
Vivos Therapeutics, Inc. Receives FDA Clearance to Vivos Care Oral Appliances to Treat Severe OSA in Adults	06/02
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA	08/01
Vivos Therapeutics, Inc. Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA	08/01
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”	11/12
Top Premarket Decliners	30/11
Health Care Drops Amid Skepticism About Cigna, Humana Deal -- Health Care Roundup	29/11
Sector Update: Health Care Stocks Mixed Late Afternoon	29/11
Top Midday Gainers	29/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Vivos Therapeutics, Inc.

Actions

VVOS

US92859E2072

Autres langues

Filtres